Penn Center for Myeloproliferative Neoplasms

Daria V. Babushok

faculty photo

Daria V. Babushok

Instructor A of Medicine
Department: Medicine

Contact information
Perelman Center for Advanced Medicine
12th Floor West Pavilion
3400 Civic Center Blvd
Philadelphia, PA 19104
Office: 2156141847
Fax: 215-615-5888
Education:
BA (Biology, Chemistry)
Bryn Mawr College, 2000.
PhD (Cellular and Molecular Biology)
University of Pennsylvania, 2007.
MD (Medicine)
University of Pennsylvania, 2008.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

Bone marrow failure syndromes (inherited and acquired), acquired aplastic anemia, paroxysmal nocturnall hemoglobinuria, clonal hematopoiesis, MDS/AML predisposition syndromes, MPN predisposition syndromes, myeloproliferative neoplasms

Description of Research Expertise

RESEARCH INTERESTS:
The Babushok Lab conducts basic and translational research to understand the fundamental mechanisms of how bone marrow can fail, how the failure of bone marrow can lead to pre-malignant genetic changes and myelodysplastic syndrome and leukemia, and what is the relationship between our immune system and the development of clonal hematopoiesis.

We use state-of-the-art genome analysis, molecular biology and immunogenetic analyses, as well as in vitro and in vivo models to study the mechanisms of immune-mediated marrow failure and the factors that lead to the development of clonal hematopoiesis in bone marrow failure and aging.

KEYWORDS:
Clonal hematopoiesis, bone marrow failure, aplastic anemia, PNH, malignant predisposition to MDS and leukemia

ROTATION PROJECTS:
We are always looking for talented individuals who are passionate about science. There are opportunities to contribute at every level, and we welcome inquiries from undergraduate and graduate students, postdoctoral scientists, and medical students, residents, and fellows. Please contact Daria.Babushok at uphs.upenn.edu to discuss research opportunities.

SEE BABUSHOK LAB WEBSITE

LAB MEMBERS:
Kathy Guo – Research Specialist
Natasha Stanley – Research Specialist

MEDICAL STUDENT RESEARCHERS:
Taylor Linaburg – Medical Student
Tristan Lim - Medical Student

Selected Publications

Babushok DV: A Brief, But Comprehensive, Guide to Clonal Evolution in Aplastic Anemia. Hematology 2018 Dec 2018.

Aynardi J, Manur R, Hess PR, Chekol S, Morrissette JJD, Babushok D, Hexner E, Rogers HJ, Hsi ED, Margolskee E, Orazi A, Hasserjian R, Bagg A.: JAK2 V617F-positive acute myeloid leukaemia (AML): a comparison between de novo AML and secondary AML transformed from an underlying myeloproliferative neoplasm. A study from the Bone Marrow Pathology Group. Br J Haematol. May 16 2018 Notes: doi: 10.1111/bjh.15276. [Epub ahead of print]

Soderquist CR, Ewalt MD, Czuchlewski DR, Geyer JT, Rogers HJ, Hsi ED, Wang SA, Bueso-Ramos CE, Orazi A, Arber DA, Hexner EO, Babushok DV, Bagg A. : Myeloproliferative Neoplasms with Concurrent BCR-ABL1 Translocation and JAK2 V617F Mutation: a Multi-institutional Study from the Bone Marrow Pathology Group. Mod Pathol 31(5): 690-704, May 2018.

Babushok D, Bessler M. : Aplastic Anemia and Pure Red Cell Aplasia. Chapter 18. In Anemia: Pathophysiology, Diagnosis and Management. Cambridge University Press. Edward J. Benz, Nancy Berliner and Fred J. Schiffman. (eds.). Apr 30 2018 Notes: ISBN-10: 0521514266.

Sarthy J, Zha J, Babushok D, Shenoy A, Fan J-M, Wertheim G, Himebach A, Munchel A, Taraseviciute A, Yang S, Shima H, Narumi S, Meshinchi S, Olson TS. : Poor Outcome with Hematopoietic Stem Cell Transplantation for Bone Marrow Failure and MDS with Severe MIRAGE Syndrome Phenotype. Blood Adv 2(2): 120-125, Jan 23 2018.

Babushok, DV, Stanley NL, Morrissette JJD, Lieberman DB, Olson TS, Chou ST, Hexner EO: Germline duplication of ATG2B and GSKIP genes is not required for the familial myeloid malignancy syndrome associated with the duplication of chromosome 14q32. Leukemia 2018.

Babushok, DV, Nelson, EJ, Morrissette, JJD, Joshi, S, Palmer, MB, Frank, D, Cambor, CL, Hexner, EO: Myelofibrosis patients can develop extramedullary complications including renal amyloidosis and sclerosing hematopoietic tumor while otherwise meeting traditional measures of ruxolitinib response. Leukemia & Lymphoma 2018.

Peslak SA, Olson TS, Babushok DV. : Diagnosis and Treatment of Aplastic Anemia, Current Treatment Options in Oncology, Curr Treat Options Oncol 18(12): 70, Nov 16 2017.

Babushok DV, Duke JL, Xie HM, Stanley N, Atienza J, Perdigones, N, Nicholas P, Ferriola D, Li Y, Huang H, Ye W, Morrissette J, Podsakoff G, Biegel JA, Chou S, Monos DS, Bessler M, Olson TS.: Somatic HLA Mutations Expose the Role of Class I-Mediated Autoimmunity in Aplastic Anemia and its Clonal Complications. Blood Adv 1(22): 1900-1910, Oct 10 2017.

Reilly CR, Babushok DV, Martin K, Spivak JL, Streiff M, Bahirwani R, Mondschein J, Stein B, Moliterno A, Hexner EO. : Multicenter analysis of the use of transjugular intrahepatic portosystemic shunt for management of MPN-associated portal hypertension. Am J Hematol 92(9): 909-914, Sep 2017.

back to top
Last updated: 09/20/2018
The Trustees of the University of Pennsylvania
 

The Penn Difference

  • Individualized Treatment Plan
  • Expert Treatment Team Knowledgeable in Myeloproliferative Disorders
  • State-of-the-Art Personalized Diagnostic Testing
  • Access to Newest Therapies Through Clinical Trials
  • Comprehensive Bone Marrow Transplantation Service
  • Integrated Care by a Multidisciplinary Treatment Team

Make an Appointment

New Patients:
Abramson Cancer Center
Perelman Center for Advanced Medicine
2nd Floor, West Pavilion
Philadelphia, PA 19104
Phone: 215-615-5858 option 2
Fax: 215-615-5889

Current Patients:
Contact your doctor directly

For General Inquiries:
Call the Myeloproliferative Neoplasms Program at  215-614-1847


Donate


Search